These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30687565)

  • 1.
    Porritt RA; Crother TR
    For Immunopathol Dis Therap; 2016; 7(3-4):237-254. PubMed ID: 30687565
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary
    Cheok YY; Lee CYQ; Cheong HC; Looi CY; Wong WF
    Microorganisms; 2020 Jan; 8(1):. PubMed ID: 31963395
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Chlamydia pneumoniae candidate genes that interact with human apoptotic factor caspase-9.
    Aziz MA; Ushirokita R; Azuma Y
    J Gen Appl Microbiol; 2018 Nov; 64(5):253-257. PubMed ID: 29760350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae as a respiratory pathogen.
    Hahn DL; Azenabor AA; Beatty WL; Byrne GI
    Front Biosci; 2002 Mar; 7():e66-76. PubMed ID: 11861211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
    Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
    Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro.
    Haranaga S; Yamaguchi H; Friedman H; Izumi S; Yamamoto Y
    Infect Immun; 2001 Dec; 69(12):7753-9. PubMed ID: 11705957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomes of Chlamydia pneumoniae and C. trachomatis.
    Kalman S; Mitchell W; Marathe R; Lammel C; Fan J; Hyman RW; Olinger L; Grimwood J; Davis RW; Stephens RS
    Nat Genet; 1999 Apr; 21(4):385-9. PubMed ID: 10192388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chlamydia pneumoniae infections].
    Miyashita N
    Kekkaku; 2006 Sep; 81(9):581-8. PubMed ID: 17037392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of oral tolerance as treatment or prevention of chronic diseases associated with Chlamydia pneumoniae infection--hypothesis.
    Moling O; Mian P
    Med Sci Monit; 2003 May; 9(5):HY15-8. PubMed ID: 12761463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae infections and development of lung cancer: systematic review.
    Premachandra NM; Jayaweera JAAS
    Infect Agent Cancer; 2022 Mar; 17(1):11. PubMed ID: 35317845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae induces interleukin-6 and interleukin-10 in human gingival fibroblasts.
    Rizzo A; Paolillo R; Lanza AG; Guida L; Annunziata M; Carratelli CR
    Microbiol Immunol; 2008 Sep; 52(9):447-54. PubMed ID: 19039953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Chlamydia pneumoniae.
    Blasi F; Tarsia P; Arosio C; Fagetti L; Allegra L
    Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S1-S6. PubMed ID: 11869264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae.
    Song YG; Kwon HM; Kim JM; Hong BK; Kim DS; Huh AJ; Chang KH; Kim HY; Kang TS; Lee BK; Choi DH; Jang YS; Kim HS
    Yonsei Med J; 2000 Jun; 41(3):319-27. PubMed ID: 10957885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of the growth and biological activity of a respiratory and atheroma isolate of Chlamydia pneumoniae reveals strain-dependent differences in inflammatory activity and innate immune evasion.
    He X; Liang Y; LaValley MP; Lai J; Ingalls RR
    BMC Microbiol; 2015 Oct; 15():228. PubMed ID: 26494400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview.
    Kern JM; Maass V; Maass M
    Clin Microbiol Infect; 2009 Jan; 15(1):36-41. PubMed ID: 19220338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].
    Stille W; Dittmann R
    Herz; 1998 May; 23(3):185-92. PubMed ID: 9646100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.